The signalling pathways linked to acromegaly are also involved in mutation in guanine nucleotide-binding protein G(s) (GNAS1), the mutation that confers preferential responsiveness to GH inhibitory peptide SST [302,303]. The gene discussed is GH1; the disease is acromegaly.